{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:28:12Z","timestamp":1770910092909,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T00:00:00Z","timestamp":1361577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00059-013-3765-7","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T03:19:36Z","timestamp":1361416776000},"page":"931-933","source":"Crossref","is-referenced-by-count":7,"title":["Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib","Schnell fortschreitende pulmonale arterielle Hypertonie bei einem Patienten mit akuter lymphoblastischer Leuk\u00e4mie bei Dasatinibbehandlung"],"prefix":"10.1007","volume":"38","author":[{"given":"J.-C.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-I.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.-H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,23]]},"reference":[{"key":"3765_CR1","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","volume":"362","author":"Kantarjian","year":"2010","unstructured":"Kantarjian H, Shah NP, Hochhaus A et al (2010) Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 362:2260\u20132270","journal-title":"N Engl J Med"},{"key":"3765_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2011.1.231","volume":"2011","author":"Fielding","year":"2011","unstructured":"Fielding AK (2011) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2011:231\u2013237","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3765_CR3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200705-715CR","volume":"176","author":"Bergeron","year":"2007","unstructured":"Bergeron A, Rea D, Levy V et al (2007) Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med 176:814\u2013818","journal-title":"Am J Respir Crit Care Med"},{"key":"3765_CR4","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","volume":"125","author":"Montani","year":"2012","unstructured":"Montani D, Bergot E, G\u00fcnther S et al (2012) Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125:2128\u20132137","journal-title":"Circulation"},{"key":"3765_CR5","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.leukres.2011.08.007","volume":"36","author":"Orlandi","year":"2012","unstructured":"Orlandi EM, Rocca B, Pazzano AS, Ghio S (2012) Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia. Leuk Res 36:e4\u2013e6","journal-title":"Leuk Res"},{"key":"3765_CR6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1183\/09031936.00154210","volume":"38","author":"Dumitrescu","year":"2011","unstructured":"Dumitrescu D, Seck C, ten Freyhaus H et al (2011) Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J 38:218\u2013220","journal-title":"Eur Respir J"},{"key":"3765_CR7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.leukres.2008.09.026","volume":"33","author":"Rasheed","year":"2009","unstructured":"Rasheed W, Flaim B, Seymour JF (2009) Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia. Leuk Res 33:861\u2013864","journal-title":"Leuk Res"},{"key":"3765_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2466-11-30","volume":"11","author":"Hennigs","year":"2011","unstructured":"Hennigs JK, Keller G, Baumann HJ et al (2011) Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? BMC Pulm Med 11:30","journal-title":"BMC Pulm Med"},{"key":"3765_CR9","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811\u20132821","journal-title":"J Clin Invest"},{"key":"3765_CR10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/ATVBAHA.112.248500","volume":"32","author":"Pullamsetti","year":"2012","unstructured":"Pullamsetti SS, Berghausen EM, Dabral S et al (2012) Role of SRC tyrosine kinases in experimental pulmonary hypertension. Arterioscler Thromb Vasc Biol 32:1354\u20131365","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3765-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-013-3765-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3765-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T11:56:37Z","timestamp":1558526197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-013-3765-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,23]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3765"],"URL":"https:\/\/doi.org\/10.1007\/s00059-013-3765-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,23]]}}}